Alirocumab
CAS 1245916-14-6Biologic
Overview
Alirocumab is a monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9), used to lower cholesterol levels in the blood. It is primarily prescribed to patients with hypercholesterolemia who require additional lipid-lowering treatment and are intolerant or unresponsive to statins.
Therapeutic areas
CardiovascularLipid metabolism disordersHyperlipidemia
Verified Supplier Partner
Do you supply Alirocumab? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.